跳至主要内容
临床试验/CTRI/2013/10/004091
CTRI/2013/10/004091招募中2 期

A Multi centric, Single Blind, Randomized, parallel groupstudy to compare efficacy and safety of coded unaniformulation UNIM-904 with Amlodipine in patients withZaghtuddam Qawi Lazmi (Essential Hypertension)

Central Council for Research in Unani Medicine CCRUM0 个研究点目标入组 480 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group of 18-65 years.
  • 2. Patients of Hypertension with SBP 160-179 mmHg and DBP 90-100 mmHg
  • 3.Presence of any of the following signs and symptoms:
  • Suda (Headache)
  • Duwar (Vertigo)
  • Khafaqan (Palpitation)
  • Kasal (Laziness)
  • Qalaq (Anxiety)
  • Usr al-Tanaffus (Breathlessness)
  • Takaddur fiâ??l Hawas (Diminished Alertness)
  • Jiryan al-Dam zer Multahima (Subconjunctival Haemorrhage)
  • Ruâ??af (Epistaxis)
  • Nabz Mumtali (Pulsus plenus)

排除标准

  • 1.Patient with SBP >=180 mmHg and DBP 100 mmHg
  • 2.Patients of Secondary Hypertension
  • 3.Pregnant and lactating women
  • 4.Females using oral contraceptive pills
  • 5.Patients taking any other medication affecting blood pressure like
  • 6.Abnormality in investigations done at baseline (SGPT 105 IU)
  • 7.Obese subjects â?? BMI 30
  • 8.Disorders requiring long term-treatment, e.g, diabetes mellitus
  • 9.Drug addicts, Alcoholics /Malignancy /Epilepsy /CAD/CKD
  • 10.Patients with Sinus Bradycardia, i.e., pulse rate less than 60/min

研究者

发起方
Central Council for Research in Unani Medicine CCRUM

相似试验